About Antimicrobial Resistance Investments

About Antimicrobial Resistance Investments & Action - CDC

Key points. CDC's Antimicrobial Resistance Solutions Initiative invests in national infrastructure to detect, respond, contain and prevent ...

Antimicrobial Resistance Investment Map and Funding - CDC

The map currently shows fiscal year 2023 extramural funds that support CDC's antimicrobial resistance activities.

Investor Action on Antimicrobial Resistance

A collaboration between the FAIRR Initiative, the Access to Medicine Foundation, the Principles for Responsible Investment, and the UK Government to ...

SHEA Urges Investment Given Rise of Antimicrobial Resistance ...

The Society for Healthcare Epidemiology of America (SHEA) calls for full support of CDC programs combatting antibiotic resistance.

About Us - AMR Action Fund

The AMR Action Fund aims to bring 2-4 new antibiotics to patients by 2030, by enabling sustainable investment in the antibiotic pipeline.

WHO Investment case deep dive: antimicrobial resistance

The investment case deep dive takes a closer look at WHO's work in antimicrobial resistance (AMR). It examines the growing global threat ...

Investors can play 'pivotal role' in addressing antimicrobial ... - CIDRAP

A new report lays out the financial risks posed by antimicrobial resistance (AMR) and how investors might be able to mitigate them.

An investor's guide to antimicrobial resistance

The guide details a series of questions designed to help investors bring an AMR lens to engagement by industry.

AMR: How financing models can help tackle antimicrobial resistance

'Delinkage' is emerging as a promising model, according to ReAct – the network for Action on Antibiotic Resistance, which can “pay for Research ...

How we're collaborating to address antimicrobial resistance

The fund's collective goal is to bring two to four novel antibiotics to patients and physicians by 2030. As of early 2023, the AMR Action Fund ...

AMR Action Fund: Antimicrobial Resistance Research & Development

Aiming to overcome technical and funding barriers in antibiotic development and ensuring a sustainable pipeline of new antibiotics to fight superbugs.

Antimicrobial Resistance (AMR) - World Bank

Antimicrobial resistance (AMR) occurs when microbes mutate or adapt in ways that enable them to withstand antimicrobials, rendering treatments ineffective.

Antimicrobial Resistance - Global Fund

Antimicrobial resistance (AMR) is one of the top 10 global public health threats. AMR occurs when disease-causing microbes evolve to withstand the effects of ...

Invest more in vaccines to reduce deaths from drug-resistant ...

The report found that vaccines against 24 pathogens could reduce the number of antibiotics needed by 22 per cent, or 2.5 billion defined daily ...

Investors call for action on microbial resistance at same level as ...

Global economic costs associated with antimicrobial resistance are likely to reach $100 trillion and lead to a 3.8% decrease in global GDP ...

Annex to the GLG Report: Towards specific commitments and action ...

The 'Building the investment case for action against antimicrobial resistance ... investments and benefits. The following formula was used ...

AMR Action Fund | IFPMA

AMR Action Fund. The industry-led AMR Action Fund organized by IFPMA is a groundbreaking USD 1 billion initiative that aims to bring 2-4 new antibiotics to ...

Health and Wealth: The Investors' Guide to Antimicrobial Resistance ...

This guide sheds light on the far-reaching impact of AMR on key sectors such as healthcare, pharmaceuticals and animal agriculture.

Combating Antimicrobial Resistance | Basic Page - USAID

Antimicrobial resistance (AMR) is a major public health concern with the ... As part of this overall effort, USAID is investing in improved country ...

The Investors' Guide to Antimicrobial Resistance (AMR), a Growing ...

Report highlights · Provides an overview of the current state of AMR · Outlines the systemic risk to investors and key investment considerations.